Document Detail


Growth hormone and insulin-like growth factor-1 in acute myocardial infarction.
MedLine Citation:
PMID:  10973769     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Growth hormone therapy after myocardial infarction improves cardiac function and survival in animals. Beneficial effects in humans are reported from studies where patients with idiopathic dilated cardiomyopathy were treated with growth hormone. We have studied the role of the endogenous growth hormone system in myocardial infarction. METHODS AND RESULTS: Fifty-two consecutive patients with acute myocardial infarction were studied during the first 5 days and at follow-up 6 and 12 weeks later. The time from chest pain onset was used in the analyses. The mean growth hormone level within the first 6 h was nearly three times higher (1.1 +/- 0.2 microg. l(-1)) than on the third day (0.4 +/- 0.05 microg. l(-1), P < 0.0002). It remained higher in patients with higher levels of cardiac enzymes, impaired left ventricular function and intense inflammatory response. Insulin-like growth factor-1 (IGF-1) declined slowly but remained within the normal range throughout the whole study period. Patients who died within 2 years had higher levels of growth hormone and lower levels of IGF-1, indicating growth hormone resistance. Endogenous levels of growth hormone or IGF-1 did not correlate with improvement in left ventricular function at 6 weeks. CONCLUSIONS: The growth hormone axis is stimulated early in acute myocardial infarction, particularly in patients with more severe cardiac damage. Whether treatment with growth hormone can be beneficial for patients with heart failure after myocardial infarction remains to be investigated.
Authors:
L Friberg; S Werner; G Eggertsen; S Ahnve
Related Documents :
17694799 - Brain natriuretic peptide--the biological marker in the diagnosis of overt congestive h...
19387249 - Analysis of n-terminal pro-b-type natriuretic peptide in patients with acute coronary s...
19466519 - Efficacy and safety of carvedilol for heart failure in children and patients with conge...
19922329 - Serum levels of nt-probnp as surrogate for cardiac amyloid burden: new evidence from ga...
20053469 - Simultaneous estimation of nt-probnp on top to mitral flow doppler echocardiography as ...
16213609 - Neurohormonal activation and diagnostic value of cardiac peptides in patients with susp...
12930269 - Partial left ventriculectomy--the third international registry report 2002.
19168239 - Multivessel coronary-ventricular fistulae and ischaemia on cardiac mri.
11525359 - Sudden death in staphylococcus aureus-associated infective endocarditis due to perforat...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European heart journal     Volume:  21     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-12-07     Completed Date:  2000-12-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1547-54     Citation Subset:  IM    
Copyright Information:
Copyright 2000 The European Society of Cardiology.
Affiliation:
Department of Cardiology, Karolinska Institutet at Huddinge Hospital, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Markers / blood
C-Reactive Protein / metabolism
Chi-Square Distribution
Echocardiography
Female
Human Growth Hormone / blood*
Humans
Hydrocortisone / blood
Insulin-Like Growth Factor I / metabolism*
Male
Middle Aged
Myocardial Infarction / blood*,  ultrasonography
Radioimmunoassay
Statistics, Nonparametric
Ventricular Dysfunction, Left / blood,  ultrasonography
Chemical
Reg. No./Substance:
0/Biological Markers; 12629-01-5/Human Growth Hormone; 50-23-7/Hydrocortisone; 67763-96-6/Insulin-Like Growth Factor I; 9007-41-4/C-Reactive Protein
Comments/Corrections
Comment In:
Eur Heart J. 2000 Sep;21(18):1499-501   [PMID:  10973763 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myo...
Next Document:  Threshold Models for Comparative Probability on Finite Sets.